Comparison between Aristo Bio-Tech IPO and Eastern Logica Infoway IPO.
Aristo Bio-Tech IPO is a SME Fixed Price IPO proposed to list at NSE SME while Eastern Logica Infoway IPO is a SME Fixed Price proposed to list at BSE SME.
| Aristo Bio-Tech IPO | Eastern Logica Infoway IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Oneview Corporate Advisors Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aristo Bio-Tech IPO is up to ₹12.40 Cr whereas the issue size of the Eastern Logica Infoway IPO is up to ₹16.07 Cr. The final issue price of Aristo Bio-Tech IPO is ₹72.00 per share and of Eastern Logica Infoway IPO is ₹225.00 per share.
| Aristo Bio-Tech IPO | Eastern Logica Infoway IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹72.00 per share | ₹225.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 600 shares |
| Fresh Issue Size | 17,21,600 shares | 6,25,200 shares |
| Fresh Issue Size (Amount) | up to ₹12.40 Cr | up to ₹14.07 Cr |
| OFS Issue Size | 0 shares | 88,800 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹2.00 Cr |
| Issue Size Total | 17,21,600 shares | 7,14,000 shares |
| Issue Size Total (Amount) | up to ₹12.40 Cr | up to ₹16.07 Cr |
Aristo Bio-Tech IPO opens on Jan 16, 2023, while Eastern Logica Infoway IPO opens on Jan 05, 2023. The closing date of Aristo Bio-Tech IPO and Eastern Logica Infoway IPO is Jan 19, 2023, and Jan 09, 2023, respectively.
| Aristo Bio-Tech IPO | Eastern Logica Infoway IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 16, 2023 | Jan 05, 2023 |
| Issue Close | Jan 19, 2023 | Jan 09, 2023 |
| Basis Of Allotment (Tentative) | Jan 24, 2023 | Jan 12, 2023 |
| Initiation of Refunds (Tentative) | Jan 25, 2023 | Jan 13, 2023 |
| Credit of Share (Tentative) | Jan 27, 2023 | Jan 16, 2023 |
| Listing date (Tentative) | Jan 30, 2023 | Jan 17, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Aristo Bio-Tech IPO P/E ratio is 9.46, as compared to Eastern Logica Infoway IPO P/E ratio of 24.09.
| Aristo Bio-Tech IPO | Eastern Logica Infoway IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.37 | 73.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 9.46 | 24.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹49.02 Cr. | ₹64.14 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 29.26 | 8.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 35.64 | 20.34 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 5.10 | 1.72 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.93 | ₹13.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 10 | 8.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aristo Bio-Tech IPO Retail Individual Investors (RII) are offered 8,60,800 shares while in Eastern Logica Infoway IPO retail investors are offered 8,60,800 shares. Qualified Institutional Buyers (QIB) are offered in Aristo Bio-Tech IPO and in Eastern Logica Infoway IPO.
| Aristo Bio-Tech IPO | Eastern Logica Infoway IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 91,200 shares | 39,000 shares |
| QIB | ||
| NII | 8,60,800 shares | 3,57,000 shares |
| RII | 8,60,800 shares | 3,57,000 shares |
| Employee | ||
| Others | ||
| Total | 17,21,600 shares | 7,14,000 shares |
Aristo Bio-Tech IPO subscribed 217.72x in total, whereas Eastern Logica Infoway IPO subscribed 1.74x.
| Aristo Bio-Tech IPO | Eastern Logica Infoway IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 285.84x | 1.92x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 149.59x | 1.56x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 217.72x | 1.74x |
